[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Plosa et al., 2012 - Google Patents

Cytomegalovirus infection

Plosa et al., 2012

Document ID
17374165826088099619
Author
Plosa E
Esbenshade J
Fuller M
Weitkamp J
Publication year
Publication venue
Pediatrics in review

External Links

Snippet

Cytomegalovirus (CMV) has been identified as an important viral pathogen in humans for more than a century. The histopathology of CMV was first described in 1904, but the virus itself was not isolated until 1957 by Craig et al.(1) CMV infects multiple human cell types …
Continue reading at publications.aap.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—AIDS or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral

Similar Documents

Publication Publication Date Title
Plosa et al. Cytomegalovirus infection
Munro et al. Cytomegalovirus retinitis in HIV and non-HIV individuals
Davis et al. Cytomegalovirus infection in pregnancy
Sauerbrei Herpes genitalis: diagnosis, treatment and prevention
Lim et al. Congenital cytomegalovirus–who, when, what-with and why to treat?
Scarpini et al. Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice
Boeckh et al. Cytomegalovirus: pathogen, paradigm, and puzzle
Adler et al. Cytomegalovirus infections
Neu et al. TORCH infections
Bates et al. Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
Elbez-Rubinstein et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection, and review
Nyholm et al. Prevention of maternal cytomegalovirus infection: current status and future prospects
Pesch et al. Emerging concepts in congenital cytomegalovirus
Adler et al. Findings and conclusions from CMV hyperimmune globulin treatment trials
Milligan et al. The role of cell-associated virus in mother-to-child HIV transmission
Stockmann et al. Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection
Seidel et al. Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature
Griffiths Strategies to prevent CMV infection in the neonate
Siberry Preventing and managing HIV infection in infants, children, and adolescents in the United States
Van Der Beek et al. Persistence and antiviral resistance of varicella zoster virus in hematological patients
Filteau et al. Cytomegalovirus infection may contribute to the reduced immune function, growth, development, and health of HIV-exposed, uninfected African children
Bateman et al. Cytomegalovirus infections in children with primary and secondary immune deficiencies
Pinninti et al. Cytomegalovirus and Epstein-Barr virus infections
Bartlett et al. Fetal therapies for cytomegalovirus: What we tell prospective parents
Nigro et al. Prevention of Congenital Cytomegalovirus Infection: Review and Case Series of Valaciclovir versus Hyperimmune Globulin Therapy